project | inheritance | phenotype | gene function | expression | panels | hyperlinks | |
Carpenter 29990_663126 | ??? |
bookmark results refine your query |
rank | genesymbol | title | score | % | reported diseases & mutations | variants | ||||||||||||||||||
1 | RAB23 | RAB23, member RAS oncogene family | 0.5 | 100% | known disease mutation germline, loss of function, autosomal recessive, loss of function |
6:57059568C>G homo DM
IGV 999x V161L rs1060505026 not in ExAC or 1000G. | ||||||||||||||||||
2 | PRIM2 | DNA primase subunit 2 | 0.0 | 0% | 6:57398201T>C homo
IGV 999x C302R
6:57398226T>G homo IGV 999x V310G
| |||||||||||||||||||
3 | TRAM2 | translocation associated membrane protein 2 | 0.0 | 0% | 6:52370454C>G homo
IGV 999x R273P
| |||||||||||||||||||
4 | LRRC1 | leucine rich repeat containing 1 | 0.0 | 0% | 6:53778661T>G homo
IGV 999x C334G
|
genesymbol | type | description | chr. | startpos | endpos | synonyms | ||
RAB23 #1 | protein-coding | 6 | 57051790 | 57087105 | HSPC137, MGC8900, DKFZp781H0695 | |||
reported mutations | germline, loss of function, autosomal recessive, loss of function | |||||||
overall score | 0.5 | 100% | ||||||
ClinVar | 0.5 | |||||||
links | NCBI ENSEMBL SwissProt GeneCards STRING PubMed PubMed+phenotype | |||||||
KEGG pathways | Hedgehog signaling pathway | |||||||
Reactome pathways | RGGT:CHM binds RABs, RGGT geranylgeranylates RAB proteins | |||||||
WikiPathways | Genes related to primary cilium development (based on CRISPR), Ciliopathies | |||||||
PFAM | Elongation factor Tu GTP binding domain, arf; , ras; , Gtr1/RagA G protein conserved region, Miro-like protein | |||||||
InterPro domains | Small GTPase superfamily, Ran GTPase, Small GTPase superfamily, Rho type, Small GTPase superfamily, Rab type, Small GTP-binding protein domain, Small GTPase superfamily, Ras type, P-loop containing nucleoside triphosphate hydrolase | |||||||
paralogs | RAN (24%) | |||||||
HPO show all collapse |
|
|||||||
OMIM show all collapse |
CARPENTER SYNDROME 1 (CRPT1) phenotype (molecular basis known) 201000 synopsis: INHERITANCE: Autosomal recessive GROWTH: [Height] Short stature (<25th percentile) [Weight] Obesity HEAD AND NECK: [Head] Brachycephaly [Face] Midface hypoplasia [Ears] Low-set ears Malformed ears Preauricular pits Conductive hearing loss Sensorineural hearing loss [Eyes] Epicanthal folds Corneal opacity Microcornea Optic atrophy Lateral displacement of medial canthi [Nose] Flat nasal bridge [Mouth] High-arched palate [Teeth] Missing teeth Delayed loss of deciduous teeth [Neck] Short muscular neck CARDIOVASCULAR: [Heart] Atrial septal defect Ventricular septal defect Pulmonic stenosis Tetralogy of Fallot [Vascular] Transposition of great vessels Patent ductus arteriosus ABDOMEN: [External features] Umbilical hernia Omphalocele [Spleen] Accessory spleens GENITOURINARY: [Internal genitalia, male] Cryptorchidism [Kidneys] Hydronephrosis [Ureters] Hydroureter SKELETAL: [Skull] Craniosynostosis (coronal, sagittal, lambdoid sutures) [Spine] Pilonidal dimple Absent coccyx Spina bifida occulta Scoliosis [Pelvis] Coxa valga Decreased hip-joint mobility Flared ilia [Limbs] Genu valgum Lateral displacement of patellae [Hands] Brachydactyly Postaxial polydactyly Clinodactyly Syndactyly Camptodactyly [Feet] Preaxial polydactyly Syndactyly Metatarsus varus NEUROLOGIC: [Central nervous system] Variable delay (IQ range 52-104) ENDOCRINE FEATURES: Precocious puberty MOLECULAR BASIS: Caused by mutation in the Ras-associated protein RAB23 gene (RAB23, 606144.0001) text: A number sign (#) is used with this entry because of evidence that Carpenter syndrome is caused by homozygous mutation in the RAB23 gene (606144)on chromosome 6p11. CLINICAL FEATURES Carpenter (1909) described 2 sisters and a brother with acrocephaly, peculiar facies, brachydactyly, and syndactyly in the hands, and preaxial polydactyly and syndactyly of the toes. Temtamy (1966) could find 9 other reported cases and added one. In older patients obesity, mental retardation, and hypogonadism had been noted. In all cases the parents have been normal. Parental consanguinity was suspected in 1 case. The case of acrocephalosyndactyly with foot polydactyly reported by Owen (1952) probably represented Carpenter syndrome, as do the sibs reported by Schonenberg and Scheidhauer (1966). One patient thought to have this condition by Palacios and Schimke (1969) was 49 years old. Eaton et al. (1974) reported affected sibs. Cohen et al. (1987) described 2 affected sibs showing marked intrafamilial variability. This experience and a review of the literature suggested that the Goodman syndrome (201020) and the Summitt syndrome (272350) fall well within the clinical spectrum of the Carpenter syndrome. Gershoni-Baruch (1990) described a brother and sister with rather striking differences in severity. The first born had craniosynostosis of the sagittal suture, normal intelligence, and no abnormalities of the hands and feet. The second born sib had polysyndactyly of hands and feet, normal intelligence, and no craniosynostosis. Gershoni-Baruch (1990) suggested that polysyndactyly is not an absolute requisite for the diagnosis of Carpenter syndrome and that the Summitt and Goodman syndromes are 'within the clinical spectrum' of Carpenter syndrome, as suggested by Cohen et al. (1987). Alessandri et al. (2010) described 4 boys with Carpenter syndrome from a consanguineous Comoros Islands pedigree. All 4 boys presented with acrocephaly and polysyndactyly, but displayed variable severity of craniosynostosis ranging from cloverleaf skull to predominant involvement of the metopic ridge (turricephaly). All of the children also had a combination of brachydactyly with agenesis of the middle phalanges, syndactyly, broad thumbs, and postaxial polydactyly in the hands, with preaxial polydactyly and syndactyly of the toes. Mental development was normal in all; brain imaging showed hydrocephalus in 2 of the 4 boys. Additional features included corneal anomaly in 2, cryptorchidism in 3, umbilical hernia in 1, genu valgum in 2, umbilical hernia in 1, severe kyphoscoliosis in 1, patent ductus arteriosus in 1, and accessory spleen in 1. MAPPING Using homozygosity mapping, Jenkins et al. (2007) found linkage of Carpenter syndrome to chromosome 6p12.1-q12. MOLECULAR GENETICS In 15 independent families with Carpenter syndrome, Jenkins et al. (2007) identified 5 different mutations (4 truncating and 1 missense) in the RAB23 gene (see, e.g., L145X, 606144.0001; 606144.0002), which encodes a member of the RAB guanosine triphosphatase (GTPase) family of vesicle transport proteins and acts as a negative regulator of hedgehog (HH) signaling (see 600725). In 10 patients, the disease was caused by homozygosity for the same L145X mutation that resides on a common haplotype, indicative of a founder effect in patients of northern European descent. In 4 boys with Carpenter syndrome from a consanguineous Comoros Islands pedigree, Alessandri et al. (2010) identified homozygosity for a 1-bp duplication in the RAB23 gene (606144.0003). NOMENCLATURE The designation of Carpenter syndrome as ACPS II is a relict of an earlier classification that made the Noack syndrome ACPS I. It is now agreed by most that Noack syndrome is the same as Pfeiffer syndrome (101600). RAS-ASSOCIATED PROTEIN RAB23 (RAB23) gene description 606144 text: DESCRIPTION Rab proteins are small GTPases of the Ras superfamily involved in the regulation of intracellular membrane trafficking. The RAB23 gene encodes an essential negative regulator of the Sonic hedgehog (SHH; 600725) signaling pathway. For additional background information on Rab proteins, see 179508. CLONING By a map-based approach, Eggenschwiler et al. (2001) cloned the gene mutant in the mouse 'open brain 'phenotype (opb; see later) and found that it encodes Rab23, a member of the Rab family of vesicle transport proteins. The human RAB23 gene encodes a 237-amino acid protein. RAB23 is 30 to 35% identical to other mammalian Rab proteins and includes all the canonical motifs required for guanine nucleotide binding, GTP hydrolysis, membrane association, and the conformational switch between the GTP and GDP-bound state. Rab23 is a relatively divergent Rab protein with an unusually long carboxy-terminal tail. In the mouse at embryonic day 10.5, Rab23 RNA was present at low levels in most tissues, and was present at high levels in the spinal cord, somites, limb buds, and cranial mesenchyme. In the spinal cord, Rab23 was expressed at highest levels in the dorsal half of the neural tube, although it was excluded from the roof plate. In the limb bud, it was expressed in the crescent of mesenchymal cells that are capable of responding to Shh signaling. The expression pattern of Rab23 RNA is similar to that of Gli3 (165240), another negative regulator of the Shh signaling pathway. GENE STRUCTURE The RAB23 gene contains 8 exons, and the first 2 exons are noncoding (Alessandri et al., 2010). MAPPING By database searching, Zhang et al. (2000) mapped the RAB23 gene to chromosome 6p11 based on similarity between the RAB23 sequence (GenBank GENBANK AF 161486) and previously mapped sequences. GENE FUNCTION Mutations in Shh and opb cause opposing transformations in neural cell fate: Shh mutant embryos lack ventral cell types throughout the spinal cord, whereas opb mutant embryos lack dorsal cell types specifically in the caudal spinal cord. Eggenschwiler et al. (2001) demonstrated that opb acts downstream of Shh. Ventral cell types that are absent in Shh mutants, including the floor plate, are present in Shh-opb double mutants. The organization of ventral cell types in Shh-opb double mutants reveals that Shh-independent mechanisms can pattern the neural tube along its dorsal-ventral axis. Eggenschwiler et al. (2001) concluded that dorsalizing signals activate transcription of Rab23 in order to silence the Shh pathway in dorsal neural cells. MOLECULAR GENETICS Carpenter syndrome (201000) is a pleiotropic disorder with autosomal recessive inheritance, the cardinal features of which include craniosynostosis, polysyndactyly, obesity, and cardiac defects. In 15 independent families with Carpenter syndrome, Jenkins et al. (2007) identified 5 different mutations, including 4 truncating (see, e.g., L145X, 606144.0001; 606144.0002) and 1 missense, in the RAB23 gene. In 10 patients, the disease was caused by homozygosity for the same L145X mutation that resides on a common haplotype, indicative of a founder effect in patients of northern European descent. Nonsense mutations of Rab23 in 'open brain' mice were found to cause recessive embryonic lethality with neural tube defects, suggesting a species difference in the requirement for RAB23 during early development. The discovery of RAB23 mutations in patients with Carpenter syndrome implicated HH signaling in cranial suture biogenesis; this was an unexpected finding given that craniosynostosis is not usually associated with mutations of other HH pathway components. The finding also provides a new molecular target for studies of obesity, which is a consistent feature of Carpenter syndrome. In a consanguineous Comoros Islands pedigree with Carpenter syndrome, Alessandri et al. (2010) identified homozygosity for a 1-bp duplication in the RAB23 gene (606144.0003). ANIMAL MODEL Homozygous 'open brain' (opb) mice die during the second half of gestation, with an open neural tube in the head and spinal cord, abnormal somites, polydactyly, and poorly developed eyes (Gunther et al., 1994). Eggenschwiler et al. (2001) found that the opb mutation arises from the Rab23 gene. The opb1 allele encodes a lys-to-ter mutation at codon 39; the opb2 allele encodes an arg-to-ter mutation at codon 80. These alleles would lack the domains required for guanine nucleotide and Rab effector binding and are therefore null alleles. |
|||||||
OrphaNet | Carpenter syndrome Age of onset: Neonatal; Antenatal; Childhood Known mutations: germline, loss of function, autosomal recessive, loss of function (assessed) |
|||||||
generifs show all collapse |
|
|||||||
MGD | ||||||||
transcripts | ENST00000317483: 2986 bases (protein_coding) ENST00000468148: 1530 bases (protein_coding) |
|||||||
interactions (STRING) show all collapse |
||||||||
GeneOntology show all collapse |
|
|||||||
PRIM2 #2 | protein-coding | 6 | 57179603 | 57513376 | MGC75142, PRIM2, p58, PRIM2A | |||
reported mutations | none | |||||||
overall score | 0.0 | 0% | ||||||
links | NCBI ENSEMBL GeneCards STRING PubMed PubMed+phenotype | |||||||
KEGG pathways | Purine metabolism, Pyrimidine metabolism, Metabolic pathways, DNA replication | |||||||
Reactome pathways | The primase component of DNA polymerase:primase synthesizes a 6-10 nucleotide RNA primer at the origin, DNA polymerase alpha:primase binds at the origin, The polymerase component of DNA polymerase alpha:primase synthesizes a 20-nucleotide primer at the origin, RFC binding displaces Pol Alpha, Loading of PCNA - Sliding Clamp Formation, RFC dissociates after sliding clamp formation, Formation of Processive Complex, Formation of Okazaki fragments, Formation of the Flap Intermediate, RPA binds to the Flap, Recruitment of Dna2 endonuclease, Removal of RNA primer and dissociation of RPA and Dna2, Removal of remaining Flap, Detection of damage during initiation of DNA synthesis in S-phase, The primase component of DNA polymerase:primase synthesizes a 6-10 nucleotide RNA primer on the G strand of the telomere, The polymerase component of DNA polymerase alpha:primase synthesizes a 20-nucleotide primer on the G strand of the telomere, RFC binding displaces Pol Alpha on the C-strand of the telomere, DNA polymerase:primase binds G-strand of the telomere, Decitabine triphosphate incorporates into DNA | |||||||
WikiPathways | G1 to S cell cycle control, DNA replication, Pyrimidine metabolism | |||||||
PFAM | Eukaryotic and archaeal DNA primase, large subunit | |||||||
InterPro domains | DNA primase large subunit, eukaryotic/archaeal | |||||||
OMIM show all collapse |
PRIMASE POLYPEPTIDE 2A (PRIM2A) gene description 176636 text: DESCRIPTION DNA replication in human cells is initiated by a complex apparatus containing a DNA polymerase-alpha/primase complex that is well conserved from yeast to human. The DNA polymerase-alpha/primase complex contains 4 subunits: the polymerase-alpha p180 (POLA; 312040) and p68 (POLA2) subunits, and the primase p58 (PRIM2A) and p49 (PRIM1; 176635) subunits. Primase synthesizes oligoribonucleotides that serve as primers for the initiation of DNA synthesis. It plays a role in both the initiation of DNA replication and the synthesis of Okazaki fragments for lagging strand synthesis (Shiratori et al., 1995). CLONING By RT-PCR of embryonic kidney cell line RNA using degenerate primers based on mouse and yeast primase subunits, followed by 5-prime RACE, Stadlbauer et al. (1994) cloned the primase p58 subunit. The deduced 446-amino acid protein shares 89% identity with mouse p58, with 5 regions of homology distributed over the central part of the protein. The N and C termini are less well conserved. GENE FUNCTION Stadlbauer et al. (1994) demonstrated that mouse and human p58 showed no primase activity in the absence of p48. Zerbe and Kuchta (2002) found that deletion of met288 to leu313 within the polymerase-beta (174760)-like domain of human p58 resulted in a protein that bound to the primase p49 subunit but was unable to support primer synthesis on any template when assays contained only Mg(2+). Including Mn(2+), a metal that stimulates initiation of primer synthesis, allowed the p49/p58 primase complex to synthesize primers at a rate only moderately lower than that of the wildtype enzyme on templates consisting only of deoxycytidylates. By point mutagenesis, Zerbe and Kuchta (2002) determined that arg302, arg306, and lys314 were required for both primer initiation and translocation. Conversion of these residues to alanine interfered with initiation and significantly decreased the processivity of primase. Zerbe and Kuchta (2002) concluded that the polymerase-beta-like region of p58 is important for primer initiation, translocation, and counting. MAPPING By PCR amplification using DNAs from a panel of somatic cell hybrids, Shiratori et al. (1995) mapped the PRIM1 gene and the PRIM2 gene to chromosomes 1 and 6, respectively. By fluorescence in situ hybridization using several genomic DNA probes, they mapped the PRIM1 gene to 1q44 and two PRIM2 loci (PRIM2A and PRIM2B) to 6p12-p11.1. In an erratum to Shiratori et al. (1995), the authors stated that the gene on 1q44 was in fact a processed PRIM1 pseudogene (PRIM1P). The PRIM2B locus identified by Shiratori et al. (1995) may also be a pseudogene (Scott, 2004). |
|||||||
generifs |
|
|||||||
transcripts | ENST00000389488: 2290 bases (processed_transcript) ENST00000607273: 2290 bases (protein_coding) ENST00000419977: 2197 bases (retained_intron) ENST00000370687: 909 bases (processed_transcript) ENST00000274891: 864 bases (processed_transcript) ENST00000470638: 486 bases (processed_transcript) ENST00000490313: 410 bases (processed_transcript) ENST00000550475: 391 bases (processed_transcript) |
|||||||
interactions (STRING) show all collapse |
||||||||
GeneOntology | ||||||||
TRAM2 #3 | protein-coding | 6 | 52362206 | 52441858 | KIAA0057 | |||
reported mutations | none | |||||||
overall score | 0.0 | 0% | ||||||
links | NCBI ENSEMBL SwissProt GeneCards STRING PubMed PubMed+phenotype | |||||||
PFAM | LAG1;, TRAM1-like protein | |||||||
InterPro domains | TRAM/LAG1/CLN8 homology domain, TRAM1-like protein, Translocation associated membrane protein | |||||||
paralogs | TRAM1 (51%), TRAM1L1 (44%) | |||||||
OMIM show all collapse |
TRANSLOCATION-ASSOCIATED MEMBRANE PROTEIN 2 (TRAM2) gene description 608485 text: DESCRIPTION TRAM2 is a component of the translocon, a gated macromolecular channel that controls the posttranslational processing of nascent secretory and membrane proteins at the endoplasmic reticulum (ER) membrane. CLONING By sequencing clones obtained from a size-fractionated myeloid cell line cDNA library, Nomura et al. (1994) cloned TRAM2, which they designated KIAA0057. The 3-prime untranslated region of the transcript contains an Alu repeat. The deduced 370-amino acid protein contains possible transmembrane domains. TRAM2 shares 51.6% identity with human RA-regulated nuclear matrix associated protein, RAMP (602221). Northern blot analysis detected moderate expression in all tissues examined except brain. Using the sequence of KIAA0057 to design primers, Onuchic et al. (1999) amplified TRAM2 from kidney cDNA. TRAM2 shares 68% homology with TRAM1 (605190). Northern blot analysis detected 7.0-kb and 0.8-kb TRAM2 transcripts in fetal lung, liver, and kidney. Only the 0.8-kb transcript was detected in fetal brain. Stefanovic et al.(2004) cloned human and rat TRAM2 by differential display of activated and quiescent hepatic stellate cells. The deduced protein contains 7 putative transmembrane regions and shows the same topology as that predicted for TRAM1, but TRAM2 differs at the C terminus. GENE FUNCTION Upon activation, quiescent hepatic stellate cells proliferate, change morphologically into myofibroblasts, and increase their synthesis of extracellular matrix proteins. Stefanovic et al. (2004) demonstrated that both TRAM2 and collagen type I (see 120150) are upregulated in activated rat and human hepatic stellate cells. By yeast 2-hybrid screen and in vitro binding assays, they further found that the C terminus of TRAM2 interacts with SERCA2b (108740), the main Ca(2+) pump in the endoplasmic reticulum of hepatic stellate cells and fibroblasts. TRAM2 also coprecipitated with collagen. Deletion of the C terminus of TRAM2, and pharmacologic inhibitors of SERCA2b, inhibited type I collagen synthesis. In addition, depletion of ER Ca(2+) inhibited the folding of triple helical collagen and increased its intracellular degradation. Stefanovic et al. (2004) proposed that, during activation of hepatic stellate cells, TRAM2 recruits SERCA2b to the translocon, and SERCA2b then couples procollagen synthesis and Ca(2+)-dependent molecular chaperones involved in collagen folding. GENE STRUCTURE Onuchic et al. (1999) determined that the TRAM2 gene contains 11 exons and spans 79.6 kb. MAPPING By PCR of a human/rodent hybrid panel, Nomura et al. (1994) mapped the TRAM2 gene to chromosome 6. By genomic sequence analysis, Onuchic et al. (1999) mapped the TRAM2 gene to chromosome 6p21.1-p12 near the PKHD1 (606702) gene. |
|||||||
generifs |
|
|||||||
MGD | ||||||||
transcripts | ENST00000182527: 6908 bases (protein_coding) | |||||||
interactions (STRING) show all collapse |
||||||||
GeneOntology | ||||||||
LRRC1 #4 | protein-coding | 6 | 53659803 | 53788923 | FLJ10775, dJ523E19.1, LANO, FLJ11834 | |||
reported mutations | none | |||||||
overall score | 0.0 | 0% | ||||||
links | NCBI ENSEMBL SwissProt GeneCards STRING PubMed PubMed+phenotype | |||||||
Reactome pathways | RND2 binds effectors | |||||||
PFAM | LRR; | |||||||
InterPro domains | Leucine-rich repeat, Leucine-rich repeat, typical subtype, Leucine rich repeat 4 | |||||||
paralogs | LRRC8E (17%), LRRC8A (19%), LRRIQ4 (23%), LRRD1 (15%), MFHAS1 (13%), RSU1 (21%), SHOC2 (22%), LOC101927933 (11%), LRRC8D (11%), LRRC8B (13%), SCRIB (20%), ERBIN (15%), LRRC7 (14%), LRRC40 (19%) | |||||||
OMIM show all collapse |
LEUCINE-RICH REPEAT-CONTAINING PROTEIN 1 (LRRC1) gene description 608195 text: CLONING By searching an EST database for sequences similar to scribble (607733) and erbin (606944), followed by RACE of breast mRNA, Saito et al. (2001) cloned LRRC1, which they designated LANO. The deduced protein contains 16 leucine-rich repeats and a LAP-specific domain, but no PDZ domain. LRRC1 shares 60%, 42%, and 40% amino acid identity with scribble, rat densin-180, and erbin, respectively. Northern blot analysis detected a 3.5-kb transcript expressed predominantly in placenta, kidney, pancreas, prostate, testis, colon, thyroid, and adrenergic glands. Western blot analysis detected endogenous LRRC1 at an apparent molecular mass of about 62 kD in a human colon epithelial (Caco2) cell line. Immunolocalization and confocal sections of permeabilized Caco2 cells detected LRRC1 expression on the basolateral surface. GENE FUNCTION By in vitro and in vivo pull-down assays with transfected Caco2 cells, Saito et al. (2001) demonstrated that LRRC1 and a C-terminal LRRC1 peptide interacted with the PDZ domains of DLG1 (601014) and PSD95 (DLG4; 602887). They found a second pool of LRRC1 in a complex with erbin. MAPPING Saito et al. (2001) stated that the LRRC1 gene maps to chromosome 6p12.3-p12.2. |
|||||||
generifs |
|
|||||||
transcripts | ENST00000370888: 3180 bases (protein_coding) ENST00000487251: 2527 bases (nonsense_mediated_decay) ENST00000370882: 808 bases (protein_coding) ENST00000490222: 555 bases (retained_intron) |
|||||||
interactions (STRING) show all collapse |
||||||||
GeneOntology | ||||||||
bookmarks
your settings in the query mask | this output |
citing MutationDistiller
If you feel that MutationDistiller has helped you in your research, please cite the following publication: MutationDistiller: user-driven identification of pathogenic DNA variants. Hombach D, Schuelke M, Knierim E, Ehmke N, Schwarz JM, Fischer-Zirnsak B, Seelow D. Nucleic Acids Res. 2019 May 20. pii: gkz330. doi: 10.1093/nar/gkz330. Read the paper |
entity | last update (YYYY-MM-DD) |
ClinVar | 2018-08-06 |
Ensembl transcripts:Genbank | 2016-08-15 |
Ensembl:Entrez | 2019-10-28 |
Entrez gene RIFS | 2019-10-28 |
Entrez gene history | 2019-10-28 |
Entrez gene positions | 2024-03-13 |
Entrez gene synonyms | 2019-10-28 |
Entrez genes | 2019-10-28 |
Maestro/Mitopred | 2016-08-15 |
OMIM | 2019-09-10 |
UCSC IDs | 2016-08-15 |